Dr. Cory L. Simpson, MD, PhD

Dr. Simpson practices at UW Medical Center - Montlake in Seattle, Washington, part of University of Washington.

Dr. Simpson's NPI, 1134474356, was assigned on July 14, 2012. Dr. Simpson holds Washington license MD61189841.

Dr. Simpson's primary practice is UW Medical Center - Montlake, at 1959 NE Pacific St Box 356151, Seattle, WA 98195 in King County. The practice phone is (206) 598-3300.

Dr. Simpson's primary practice is UW Medical Center - Montlake in Seattle, Washington, part of University of Washington. The medical group on file is Penn Medicine Lancaster General Health. Dmand AI also links Dr. Simpson to 1 more hospital, 1 hospital outpatient department and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Simpson practices, 3 sites in all. Vendor and product names are available with a free account.

Dermatology is Dr. Simpson's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Simpson is licensed in Washington.

CMS data shows 152 Medicare services from Dr. Simpson across 3 procedure codes in 2024, for 40 Medicare patients. Medicare paid $8,256 for them. Every service was in an office.

CMS counts 40 Medicare patients who saw Dr. Simpson in 2024. The largest group is 75 to 84, with 18 patients. 55% of them have high blood pressure, and 43% have high cholesterol. Their average risk score is 1.31, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Simpson's median patient age at 67, with 52% women.

In 2024, Dr. Simpson wrote 305 Medicare Part D claims for 47 patients. 97% of them were for generic drugs. CMS names the drug for 211 of them, across 8 drugs with 11 or more claims each, at $6,183 in total drug cost. In 2023, CMS named 217 claims across 8 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 94 out of 100 for Dr. Simpson for performance year 2024, reported through an alternative payment model (APM). Dr. Simpson accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Simpson as offering telehealth. CMS counts 14 procedures of removal of skin lesions by Dr. Simpson, more than 61% of the clinicians it reports for that procedure.

Removal or shaving of skin growth: 1 to 10 procedures (CMS shows small counts as a range)

Skin biopsy: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 26 papers to Dr. Simpson, published from 2010 to 2025. 2018 was the busiest year, with 3. The most frequent topics are Keratinocytes, Cell Differentiation and Epidermis. Dr. Simpson has published most often in bioRxiv. Dr. Simpson's most frequent co-authors are Brian Curran Capell, MD, Emily Y. Chu, MD and Peter Chansky, MD.

CMS Open Payments shows 15 general payments to Dr. Simpson from 5 drug and device companies from 2022 to 2025. Consulting fees make up the largest share, 97% of the total. Mitsubishi Tanabe Pharma America, Inc. paid the most, $7,605.